The effect of aryl hydrocarbon receptor ligands on the expression of AhR, AhRR, ARNT, Hif1α, CYP1A1 and NQO1 genes in rat liver

Toxicology Letters

Volumn 167, Issue 3, 2006, Pages 212-220

  Brauze, Damian ^a   Widerak, Magdalena ^a   Cwykiel, Joanna ^a   Szyfter, Krzysztof ^a   Baer Dubowska, Wanda ^b  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Naphthoflavone; 2,3,7,8 Tetrachlorodibenzo p dioxin; 3 Methylcholanthrene; AhR; ARNT; CYP1A1

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 3 METHYLCHOLANTHRENE; AROMATIC HYDROCARBON RECEPTOR; BETA NAPHTHOFLAVONE; CYTOCHROME P450 1A1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME MECHANISM; ENZYME RELEASE; FEMALE; LIGAND BINDING; LIVER MICROSOME METABOLISM; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEPTOR INTRINSIC ACTIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION; XENOBIOTIC METABOLISM;

ANIMALS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BETA-NAPHTHOFLAVONE; CYTOCHROME P-450 CYP1A1; FEMALE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LIGANDS; LIVER; METHYLCHOLANTHRENE; NAD(P)H DEHYDROGENASE (QUINONE); RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ARYL HYDROCARBON; REPRESSOR PROTEINS; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN;

EID: 33751194683     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2006.09.010     Document Type: Article

References (52)

1. Brauze D. Comparison of the induction of a 4S beta-naphthoflavone-binding protein, cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase in beta-naphthoflavone-treated rats. Toxicol. Lett. 152 (2004) 111-116
2. Brauze D., and Malejka-Giganti D. A novel 4S[3H]beta-naphthoflavone-binding protein in liver cytosol of female Sprague-Dawley rats treated with aryl hydrocarbon receptor agonists. Biochem. J. 347 (2000) 787-795
3. Brauze D., Mikstacka R., and Baer Dubowska W. Formation and persistence of benzo[a]pyrene-DNA adducts in different tissues of C57BL/10 and DBA/2 mice. Carcinogenesis 12 (1991) 1607-1611
4. Brauze D., Wielgosz S.M., Pawlak A.L., and Baer Dubowska W. Effect of the route of benzo[a]pyrene administration on sister chromatid exchange and DNA binding in bone marrow of mice differing with respect to cytochrome P450 1A1 induction. Toxicol. Lett. 91 (1997) 211-217
5. Chan W.K., Yao G., Gu Y.Z., and Bradfield C.A. Cross-talk between the aryl hydrocarbon receptor and hypoxia inducible factor signaling pathways. Demonstration of competition and compensation. J. Biol. Chem. 274 (1999) 12115-12123
6. Denison M.S., and Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 309-334
7. Denison M.S., Pandini A., Nagy S.R., Baldwin E.P., and Bonati L. Ligand binding and activation of the Ah receptor. Chem. Biol. Interact. 141 (2002) 3-24
8. Franc M.A., Pohjanvirta R., Tuomisto J., and Okey A.B. In vivo up-regulation of aryl hydrocarbon receptor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in a dioxin-resistant rat model. Biochem. Pharmacol. 62 (2001) 1565-1578
9. Frueh F.W., Hayashibara K.C., Brown P.O., and Whitlock Jr. J.P. Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression. Toxicol. Lett. 122 (2001) 189-203
10. Gasiewicz T.A., Kende A.S., Rucci G., Whitney B., and Willey J.J. Analysis of structural requirements for Ah receptor antagonist activity: ellipticines, flavones, and related compounds. Biochem. Pharmacol. 52 (1996) 1787-1803
11. Gasiewicz T.A., and Rucci G. Alpha-naphthoflavone acts as an antagonist of 2,3,7,8-tetrachlorodibenzo-p-dioxin by forming an inactive complex with the Ah receptor. Mol. Pharmacol. 40 (1991) 607-612
12. Giannone J.V., Li W., Probst M., and Okey A.B. Prolonged depletion of AH receptor without alteration of receptor mRNA levels after treatment of cells in culture with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol. 55 (1998) 489-497
13. Giannone J.V., Okey A.B., and Harper P.A. Characterization of polyclonal antibodies to the aromatic hydrocarbon receptor. Can. J. Physiol. Pharmacol. 73 (1995) 7-17
14. Gradin K., McGuire J., Wenger R.H., Kvietikova I., fhitelaw M.L., Toftgard R., Tora L., Gassmann M., and Poellinger L. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol. Cell Biol. 16 (1996) 5221-5231
15. Harvey J.L., Paine A.J., and Wright M.C. Disruption of endogenous regulator homeostasis underlies the mechanism of rat CYP1A1 mRNA induction by metyrapone. Biochem. J. 331 Pt 1 (1998) 273-281
16. Heid S.E., Pollenz R.S., and Swanson H.I. Role of heat shock protein 90 dissociation in mediating agonist-induced activation of the aryl hydrocarbon receptor. Mol. Pharmacol. 57 (2000) 82-92
17. Hofer T., Pohjanvirta R., Spielmann P., Viluksela M., Buchmann D.P., Wenger R.H., and Gassmann M. Simultaneous exposure of rats to dioxin and carbon monoxide reduces the xenobiotic but not the hypoxic response. Biol. Chem. 385 (2004) 291-294
18. Huff J., Lucier G., and Tritscher A. Carcinogenicity of TCDD: experimental, mechanistic, and epidemiologic evidence. Annu. Rev. Pharmacol. Toxicol. 34 (1994) 343-372
19. Kewley R.J., Whitelaw M.L., and Chapman-Smith A. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int. J. Biochem. Cell Biol. 36 (2004) 189-204
20. Korkalainen M., Tuomisto J., and Pohjanvirta R. Primary structure and inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain. Biochem. Biophys. Res. Commun. 315 (2004) 123-131
21. Ma Q., and Baldwin K.T. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced degradation of aryl hydrocarbon receptor (AhR) by the ubiquitin-proteasome pathway. Role of the transcription activation and DNA binding of AhR. J. Biol. Chem. 275 (2000) 8432-8438
22. McGuire J., Whitelaw M.L., Pongratz I., Gustafsson J.A., and Poellinger L. A cellular factor stimulates ligand-dependent release of hsp90 from the basic helix-loop-helix dioxin receptor. Mol. Cell Biol. 14 (1994) 2438-2446
23. McKillop D., and Case D.E. Mutagenicity, carcinogenicity and toxicity of beta-naphthoflavone, a potent inducer of P448. Biochem. Pharmacol. 41 (1991) 1-7
24. Miller M.S., Jones A.B., Chauhan D.P., Park S.S., and Anderson L.M. Induction of cytochrome P-450IA1 in fetal rat liver by a single dose of 3-methylcholanthrene. Biochem. Biophys. Res. Commun. 176 (1991) 280-287
25. Mimura J., Ema M., Sogawa K., and Fujii-Kuriyama Y. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev. 13 (1999) 20-25
26. Mimura J., Yamashita K., Nakamura K., Morita M., Takagi T.N., Nakao K., Ema M., Sogawa K., Yasuda M., Katsuki M., and Fujii-Kuriyama Y. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 2 (1997) 645-654
27. Moorthy B. 3-Methylcholanthrene-inducible hepatic DNA adducts: a mechanistic hypothesis linking sequence-specific DNA adducts to sustained cytochrome P4501A1 induction by 3-methylcholanthrene. Redox. Rep. 7 (2002) 9-13
28. Nebert D.W. The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit. Rev. Toxicol. 20 (1989) 153-174
29. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., and Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 59 (2000) 65-85
30. Nie M., Blankenship A.L., and Giesy J.P. Interactions between aryl hydrocarbon receptor (AhR) and hypoxia signaling pathways. Environ. Toxicol. Pharmacol. 10 (2001) 17-27
31. Nishihashi H., Kanno Y., Tomuro K., Nakahama T., and Inouye Y. Primary structure and organ-specific expression of the rat aryl hydrocarbon receptor repressor gene. Biol. Pharm. Bull. 29 (2006) 640-647
32. Okey A.B., Franc M.A., Moffat I.D., Tijet N., Boutros P.C., Korkalainen M., Tuomisto J., and Pohjanvirta R. Toxicological implications of polymorphisms in receptors for xenobiotic chemicals: the case of the aryl hydrocarbon receptor. Toxicol. Appl. Pharmacol. 207 (2005) 43-51
33. Okey A.B., Riddick D.S., and Harper P.A. The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol. Lett. 70 (1994) 1-22
34. Pelkonen O., and Nebert D.W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev. 34 (1982) 189-222
35. Petrulis J.R., and Perdew G.H. The role of chaperone proteins in the aryl hydrocarbon receptor core complex. Chem. Biol. Interact. 141 (2002) 25-40
36. Poland A., and Knutson J.C. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22 (1982) 517-554
37. Pollenz R.S. The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol. Pharmacol. 49 (1996) 391-398
38. Pollenz R.S., Davarinos N.A., and Shearer T.P. Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor. Mol. Pharmacol. 56 (1999) 1127-1137
39. Prokipcak R.D., and Okey A.B. Downregulation of the Ah receptor in mouse hepatoma cells treated in culture with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Can. J. Physiol. Pharmacol. 69 (1991) 1204-1210
40. Puga A., Maier A., and Medvedovic M. The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem. Pharmacol. 60 (2000) 1129-1142
41. Puga A., Xia Y., and Elferink C. Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem. Biol. Interact 141 (2002) 117-130
42. Radonic A., Thulke S., Mackay I.M., Landt O., Siegert W., and Nitsche A. Guideline to reference gene selection for quantitative real-time PCR. Biochem. Biophys. Res. Commun. 313 (2004) 856-862
43. Ramadoss P., Marcus C., and Perdew G.H. Role of the aryl hydrocarbon receptor in drug metabolism. Exp. Opin. Drug Metab. Toxicol. 1 (2005) 9-21
44. Reick M., Robertson R.W., Pasco D.S., and Fagan J.B. Down-regulation of nuclear aryl hydrocarbon receptor DNA-binding and transactivation functions: requirement for a labile or inducible factor. Mol. Cell Biol. 14 (1994) 5653-5660
45. Riddick D.S., Huang Y., Harper P.A., and Okey A.B. 2,3,7,8-Tetrachlorodibenzo-p-dioxin versus 3-methylcholanthrene: comparative studies of Ah receptor binding, transformation, and induction of CYP1A1. J. Biol. Chem. 269 (1994) 12118-12128
46. Safe S., Wang F., Porter W., Duan R., and McDougal A. Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicol. Lett. 102-103 (1998) 343-347
47. Santostefano M., Merchant M., Arellano L., Morrison V., Denison M.S., and Safe S. Alpha-naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation. Mol. Pharmacol. 43 (1993) 200-206
48. Sloop T.C., and Lucier G.W. Dose-dependent elevation of Ah receptor binding by TCDD in rat liver. Toxicol. Appl. Pharmacol. 88 (1987) 329-337
49. Sun Y.V., Boverhof D.R., Burgoon L.D., Fielden M.R., and Zacharewski T.R. Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences. Nucleic Acids Res. 32 (2004) 4512-4523
50. Talalay P., Dinkova-Kostova A.T., and Holtzclaw W.D. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv. Enzyme Regul. 43 (2003) 121-134
51. Tijet N., Boutros P.C., Moffat I.D., Okey A.B., Tuomisto J., and Pohjanvirta R. Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol. Pharmacol. 69 (2006) 140-153
52. Viluksela M., Bager Y., Tuomisto J.T., Scheu G., Unkila M., Pohjanvirta R., Flodstrom S., Kosma V.M., Maki-Paakkanen J., Vartiainen T., Klimm C., Schramm K.W., Warngard L., and Tuomisto J. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains. Cancer Res. 60 (2000) 6911-6920